Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $39.29 USD
Change Today -0.94 / -2.34%
Volume 668.7K
SGEN On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 5:20 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - seattle genetics inc (SGEN)

NameBoard RelationshipsTitleAge
Clay B. Siegall Ph.D.41 RelationshipsCo-Founder, Chairman, Chief Executive Officer and President54
Todd E. Simpson 5 RelationshipsChief Financial Officer and Principal Accounting Officer54
Eric L. Dobmeier J.D.15 RelationshipsChief Operating Officer46
Darren S. Cline No RelationshipsSenior Vice President of Commercial51
Jonathan Drachman M.D.13 RelationshipsChief Medical Officer and Executive Vice President of Research & Development53

Board Members - seattle genetics inc (SGEN)

NameBoard RelationshipsPrimary CompanyAge
Clay B. Siegall Ph.D.41 RelationshipsSeattle Genetics, Inc.54
Felix J. Baker Ph.D.40 RelationshipsBaker-Tisch Investments46
David W. Gryska MBA19 RelationshipsIncyte Corporation60
Nancy A. Simonian M.D.26 RelationshipsSyros Pharmaceuticals, Inc.54
Marc Estes Lippman M.D.9 RelationshipsAscenta Therapeutics, Inc.70

Executive Committees* - seattle genetics inc (SGEN)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeDavid W. Gryska MBA 19 Relationships3 Executives
Compensation CommitteeFelix J. Baker Ph.D. 40 Relationships2 Executives
Nominating CommitteeNancy A. Simonian M.D. 26 Relationships2 Executives
Corporate Governance CommitteeNancy A. Simonian M.D. 26 Relationships2 Executives
View SGEN Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SGEN:US $39.29 USD -0.94

SGEN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Genmab A/S kr628.00 DKK +25.00
Insys Therapeutics Inc $33.58 USD -0.63
Medivation Inc $87.74 USD -1.80
MorphoSys AG €62.67 EUR +0.76
Pfizer Ltd/India 2,340 INR +27.90
View Industry Companies
 

Industry Analysis

SGEN

Industry Average

Valuation SGEN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 15.9x
Price/Book 27.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 15.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEATTLE GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.